Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

ABSTRACT: RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of two different vaccines in treating patients who have cancer of the gastrointestinal tract.

DISEASE(S): Colorectal Cancer,Small Intestine Cancer,Pancreatic Cancer,Gallbladder Cancer,Extrahepatic Bile Duct Cancer,Esophageal Neoplasms,Gastric Cancer,Gallbladder Neoplasms,Bile Duct Neoplasms,Esophageal Cancer,Adenocarcinoma Of The Gallbladder,Pancreatic Neoplasms,Stomach Neoplasms,Intestinal Neoplasms,Cholangiocarcinoma

PROVIDER: 2005906 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Transcriptome profiling of organoids from the human and murine gastrointestinal tract

Project description:The epithelial layer of the gastrointestinal tract is the body’s first line of defense against gut pathogens. However, our current understanding of the innate immune response of the epithelial layer is limited. For this study, we used gastrointestinal organoids which have the advantage of being primary, non-transformed epithelium that retains organ-specific characteristics in culture, and also that they lack any confounding immune cells. We systematically profiled the transcriptomes of gastrointestinal epithelial cells using a newly generated biobank of human and murine GI organoids grown from tissue-resident stem cells, providing an atlas of gene expression along the GI tract of both species. RNA sequencing of all lines confirmed the preservation of tissue identity, and in addition revealed extensive organization of innate immune signaling components along the cephalocaudal axis, endowing a specific innate immune profile to each segment.

2020-05-23 | GSE127938 | GEO

Mus musculus gastrointestinal tract

Project description:Mus musculus gastrointestinal tract Raw sequence reads

| PRJNA801221 | ENA

Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Project description:RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have colorectal cancer that has spread to the liver.

| 2007376 | ecrin-mdr-crc

Vaccine Therapy in Treating Patients With Metastatic Cancer

Project description:RATIONALE: Vaccines made from a peptide may make the body build an immune response and kill tumor cells. PURPOSE: Randomized phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic cancer that has not responded to previous therapy.

| 2006441 | ecrin-mdr-crc

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Project description:RATIONALE: Vaccines made from mutated ras peptides may make the body build an immune response to and kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of a vaccine containing mutated ras peptides and an immune adjuvant in treating patients who have colon, pancreatic, or lung cancer.

| 2006370 | ecrin-mdr-crc

Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer

Project description:RATIONALE: Vaccines made from peptides may make the body build an immune response to kill tumor cells. PURPOSE: This clinical trial is studying how well vaccine therapy works in treating patients with stage IIB, stage III, or stage IV colorectal cancer.

| 2011380 | ecrin-mdr-crc

Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

Project description:RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. QS21 may improve the ability of the immune system to respond to disease. Combining vaccine therapy with QS21 may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy plus QS21 in treating patients who have advanced pancreatic or colorectal cancer.

| 2005419 | ecrin-mdr-crc

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Project description:RATIONALE: Vaccines made from a person’s white blood cells that have been treated in the laboratory may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have advanced or metastatic cancer.

| 2006942 | ecrin-mdr-crc

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Project description:Phase I trial to study the effectiveness of vaccine therapy with or without sargramostim in treating patients who have advanced or metastatic cancer. Vaccines may make the body build an immune response to kill tumor cells. Colony-stimulating factors such as sargramostim may increase the number of immune cells found in bone marrow or peripheral blood. Combining vaccine therapy with sargramostim may make tumor cells more sensitive to the vaccine and may kill more tumor cells

| 2007006 | ecrin-mdr-crc

mice gastrointestinal tract microbiota metagenome

Project description:mice gastrointestinal tract microbiota metagenome Raw sequence reads

| PRJNA660631 | ENA